New algorithm for the treatment of gastro‐oesophageal reflux disease
Open Access
- 31 October 2007
- journal article
- review article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 27 (3), 249-256
- https://doi.org/10.1111/j.1365-2036.2007.03565.x
Abstract
Background Gastro‐oesophageal reflux disease (GERD) is associated with a variety of typical and atypical symptoms. Patients often present in the first instance to a pharmacist or primary care physician and are subsequently referred to secondary care if initial management fails. Guidelines usually do not provide a clear guidance for all healthcare professionals with whom the patient may consult. Aim To update a 2002‐treatment algorithm for GERD, making it more applicable to pharmacists as well as doctors. Methods A panel of international experts met to discuss the principles and practice of treating GERD. Results The updated algorithm for the management of GERD can be followed by pharmacists, for over‐the‐counter medications, primary care physicians, or secondary care gastroenterologists. The algorithm emphasizes the importance of life style changes to help control the triggers for heartburn and adjuvant therapies for rapid and adequate symptom relief. Proton pump inhibitors will remain a prominent treatment for GERD; however, the use of antacids and alginate‐antacids (either alone or in combination with acid suppressants) is likely to increase. Conclusion The newly developed algorithm takes into account latest clinical practice experience, offering healthcare professionals clear and effective treatment options for the management of GERD.Keywords
This publication has 22 references indexed in Scilit:
- Can famotidine and omeprazole be combined on a once-daily basis?Scandinavian Journal of Gastroenterology, 2007
- Comparison of gastric pH with omeprazole magnesium 20.6 mg (Prilosec OTC) o.m. famotidine 10 mg (Pepcid AC) b.d. and famotidine 20 mg b.d. over 14 days of treatmentAlimentary Pharmacology & Therapeutics, 2006
- Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoringGut, 2006
- Are Lifestyle Measures Effective in Patients With Gastroesophageal Reflux Disease?Archives of Internal Medicine, 2006
- Clinical and laboratory studies of the antacid and raft‐forming properties of Rennie alginate suspensionAlimentary Pharmacology & Therapeutics, 2006
- Epidemiology of gastro-oesophageal reflux disease: a systematic reviewGut, 2005
- PPI use in the OTC era: Who to treat, with what, and for how long?Clinical Gastroenterology and Hepatology, 2005
- Clinical manifestations and complications of gastroesophageal reflux disease (GERD)International Journal of Clinical Practice, 2005
- Review article: the pathophysiology of gastro‐oesophageal reflux disease − oesophageal manifestationsAlimentary Pharmacology & Therapeutics, 2004